PT-141 (Vylessi) - 70 Day

NOT AVAILABLE FOR ALABAMA, CALIFORNIA, LOUISIANA, MICHIGAN, MISSISSIPPI, TEXAS and WASHINGTON PT-141 is a injectable peptide that activates melanocortin receptors in the brain. It significantly increases libido/erectile function in men and libido/clitoral sensitivity in women. PT-141 is sold commercially as Vylessi, a drug indicated for female hypoactive sexual desire disorder. In the literature PT-141 is also referred to as bremelanotide.  PT-141 is effective in 30-45 min and can last 24-36 hours. It is injected no more than TWICE weekly at a dose of 1 or 2mg (50 or 100 units on an insulin syringe) Since PT-141 affects melanocortin receptors it has been linked to immune system modulation (MCR-3 receptors are anti-inflammatory) and a possible reduction in stroke risk and heart disease as it promotes mild vasodilation.  Side effects are rare with the clinic's dosing regimen. Common sides include stuffy nose and cough, nausea, flushing or headache. This sides are rare if doses do not exc